Background {#Sec1}
==========

Cardiovascular diseases are dominant cause of death across the world \[[@CR1]\]. Obesity is an important risk factor for these threats and other cardiometabolic diseases such as diabetes \[[@CR2]\].

The association between body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR), indices of general or central obesity, with increased cardiometabolic risk has been proved in numerous studies \[[@CR2], [@CR3]\]. However, these measures need calibrated tools such as scale, or vary throughout a day. In contrast, neck circumference (NC) is easy to measure, constant, and time-saving measure to identify overweight and obese individuals \[[@CR4], [@CR5]\]. It has also been shown as a tool associated with central obesity \[[@CR6]\], hypertension and other components of metabolic syndrome (MetS) \[[@CR7]\]. A recent meta-analysis from six studies in children and adolescents showed that NC was moderately associated with BMI \[[@CR8]\]. To our knowledge, there has been no meta-analysis on sensitivity (SE) and specificity (SP) of NC to identify cardiometabolic risk factors, so far. Moreover, the association between NC and cardiometabolic risk factors has not been examined in child population. Accordingly, we performed a systematic review on studies which assessed NC in association with cardiometabolic risk factors, and studies which reported SE and SP of NC to identify cardiometabolic risk factors.

Methods {#Sec2}
=======

This study was designed as a systematic review on the association of NC and cardio metabolic risk factors. The main related international electronic data sources of PubMed and the NLM Gateway (for MEDLINE), Institute of Scientific Information (ISI), and Scopus searched systematically. For each, strategies were run separately regarding the detailed practical instruction including filters and refining processes. The medical subject headings, Entry Terms and Emtree options were used to reach the most sensitive search.

The strategy developed based on the search terms of MetS, cardio metabolic risk that included all of related components such as glycemic indices including diabetes mellitus, blood glucose, hemoglobin A1c (HbA1c), homeostatic model assessment (HOMA), insulin resistance (IR), lipid profiles including triglycerides (TG), low density lipoprotein (LDL), high density lipoprotein cholesterol (HDL-C), total cholesterol (TC), anthropometric measures including body mass index (BMI), waist circumference (WC), NC, overweight, generalized and abdominal obesity, and blood pressure (BP) including systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and their sub-components. At next stage these queries added to results for NC. Data refined for human subject without restriction on language.

We excluded papers of non-population-based studies or those with duplicate citation. For multiple publications of the same population, only the article with largest sample size was included.

The bibliographic information of searched studies saved using Endnote software and four independent reviewers completed all three steps of data refinement, including titles, abstracts and full texts review. Possible disagreements were resolved by third reviewer (M.Qh).

Using Cohen's kappa statistic, agreement between the results of data extraction of two experts (Sh.D, P.Ch) was 0.94. Data were collected through standard forms which contained author᾽ name, publication year, location, and type of study, sample size, age range, sex, measurements details, and interested outcomes.

Risk of bias assessment {#Sec3}
-----------------------

Risk of bias for studies which reported diagnostic accuracy of NC for predicting cardiometabolic risk factors was assessed using "quality assessment of diagnostic accuracy studies 2" (QUADAS2) checklist. This checklist includes four main methodological domains of study (sample selection, index test, gold standard, process and timing). According to this checklist studies were categorized as "low risk of bias", "high risk of bias" and "unclear". The quality assessment of observational studies which assessed association between NC and cardiometabolic risk factors was assessed using the Newcastle--Ottawa checklist which is adapted for types of study (cross sectional, case--control, cohort). In this checklist, each study can attain 9 scores for its quality. Four scores for the selection of study groups, two scores for the comparability of the groups, and three scores for the assessment of outcomes. A study with a Newcastle--Ottawa scale score of ≥ 6 was considered as high quality study. Three authors (H.A, M.Z, A.M) independently evaluated the included studies. A third author (M.M) resolved any disagreements between them.

Ethical considerations {#Sec4}
----------------------

The protocol of study was approved by the ethical committee of Alborz University of Medical Science. All reviewed studies were properly cited. For more information about a certain study, we contacted the corresponding authors.

Statistical analysis {#Sec5}
--------------------

The results of diagnostic accuracy of NC to identify MetS was presented as SE, SP and the area under the curve (AUC). The overall (pooled) SE and of SP of NC to identify MetS according to sex and age groups (pediatric and adult) was estimated using random effect meta-analysis method (using the Der-Simonian and Laird method). Forest plot also was used to present result of meta-analysis schematically.

To examine the overall correlation between NC and cardiometabolic risk factors, when r Pearson was reported a mean transformed correlation using r-to-z transformation procedure was used to obtain Fisher's Z. The standard error was also calculated based on the variance of Fisher's Z. Spearman was also converted Pearson correlation coefficients, using the following formula:$$\documentclass[12pt]{minimal}
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                \begin{document}$${\text{r}}_{{({\text{Pearson}})}} = { 2}*{ \sin }\left( {{\text{r}}_{{({\text{Spearman}})}} *\uppi/ 6} \right)$$\end{document}$$We used Der Simonian and Laird method to pool the correlation coefficients (CC). Between-study heterogeneity was assessed using the I^2^ statistic and I^2^ more than 50% considered as high heterogeneity. Findings were reported separately for adults and children. When the heterogeneity was high, we stratified the studies according to mean age (more or less than 48 years), sex (men, women, both) and continent (Asian, non-Asian) in adult populations. As the range of age in children was similar among the included studies, only sex and continent was considered for subgroup analysis. Stratification was performed when at least two studies were in each sub group. To assess publication bias when there were more than 10 effect sizes, funnel plots and Begg test was used. However, publication bias for variables with less than 10 effect sizes was examined using Egger test. P-value \< 0.05 value was considered statistically significant. All statistical analyses were performed with Stata version 12.0 (STATA Corp, College Station, TX, USA).

Results {#Sec6}
=======

Figure [1](#Fig1){ref-type="fig"} shows the selection process of articles. In total, 657 records were obtained using searching through PubMed and the NLM Gateway (for MEDLINE), ISI, and Scopus. Subsequently, 325 duplicates were removed. Articles were screened by title and abstract. In addition, 4 articles were identified through reference checking. A total of 80 full texts were assessed for eligibility and finally, 41 articles were selected. The topic of target studies were categorized as follow:Fig. 1Flowchart of study selection i)Studying diagnostic accuracy of high NC for prediction cardiometabolic risk factors (n = 21).ii)Studying association between NC and cardiometabolic risk factors (n = 33).

Some studies addressed both of these topics.

Results of qualitative synthesis {#Sec7}
--------------------------------

### A-1: The diagnostic accuracy of high NC to predict cardiometabolic risk factors {#Sec8}

A total of 21 articles (including 18 cross-sectional and 3 case--control studies) had reported SE and SP of NC for prediction of cardiometabolic risk factors. They were published between 2010 and 2016 in different countries: China (n = 4), Brazil (n = 3), USA (n = 3), India (n = 3), and 1 article in Colombia, Ukraine, Europe, Turkey, Canada, and Egypt. Eleven studies included children and adolescents and the other 10 ones assessed adults (Table [1](#Tab1){ref-type="table"}).Table 1Characteristics of the included studies which assessed diagnostic value of high neck circumference to predict cardiometabolic risk factorsStudyType of studyCountryTarget populationSam pie sizeSex ratio (M/F**)**Age yearOutco meDiagnostic criteriaCut-off values for high NCAge-sex groupSE % (95% CI)SP % (95% CI)AUC (95% CI)Silva, et al \[[@CR15]\]Cross-sectionalBrazilHealthy388169/21910--19Insulin resistanceH0MA1-IR ≥ 3.87 and HOMA1-IR ≤4.19 for females.\
H0MA1-IR ≥ 3.85 and HOMA1-IR  ≥ 3.77 for malesPrepubertal females:  \> 32.0 cmPrepubertal females76.92 (46.2-94.7)77.50 (61.5--89.1)0.84 (0.72--0.97)Pubertal females:  \> 34.1 cmPubertal females56.41 (39.6--72.2)84.75 (77.0--90.7)0.76 (0.68--0.85)Prepubertal males:  \> 30.3 cmPrepubertal males100.00 (78.0--100.0)42.55 (28.3--57.8)0.72 (0.58--0.86)Pubertal males:  \> 34.8 cmPubertal males92.00 (73.9--98.8)57.33 (45.4--68.7)0.81 (0.71--0.91)Goncalves et al. \[[@CR12]\]Cross sectionalBrazilHealthy260129/13110--14BPHigh BP:  \> 95th percentileTotal:30.2 cm, Male: 30.5 cm. Female: 29.9 cmTotal80.078.40.807 (0.754--0.854)Female100.069.50.908 (0.844--0.951)Male85.771.30.747 (0.663--0.819)TGTriglycerides  ≥ 100 mg/dLMale54.686.40.70 (0.613--0.777)HDL-CHDL-C  \< 45 mg/dLBoth sexes61.959.30.616 (0.554--0.676)Female64.564.00.645 (0.557--0.727)Insulin resistanceFasting insulin  ≥ 15 uU/mLBoth sexes72.757.30.703 (0.643--0.757)Female95.736.10.659 (0.571--0.739); p \< 0.05Male100.074.00.902 (0.837--0.947); p \< 0.001Diabet esFasting glucose  ≥ 100 mg/dLTotal080.067.50.682 (0.621--0.738); p \< 0.001Female100.075.80.827 (0.751--0.887); p \< 0.001Excess body fatBody fat 15--25% for females and 10--20% for malesTotal64.065.167.6 (0.615--0.733); p \< 0.001Female67.666.70.711 (0.625--0.786); p \< 0.001Male75.060.70.728 (0.643--0.803); p \< 0.001Torriani et al. \[[@CR37]\]Cross-sectionaUSASubjects with treated malignancies303152/15118--91MetSNCEP Adult Treatment Panel III43.6 cm in men and 38.6 cm in womenMale74 (60, 85)80 (66, 90)0.79 (0.70, 0.86)Female74 (60, 85)91 (80, 97)0.85 (0.76, 0.91)Formisano et al. \[[@CR23]\]Cross-sectionaItaly, Belgium, Cyprus, Estonia, Germany, Hungary, Spain and SwedenHealthy156737962/77113--10CMetSThe components used to calculate cMetS score were the same risk factors used in the adult MetS definition. cMetS score \> 90th percentile was considered unfavorableMale 26.25Male 3--4 years47.589.50.713 (0.622--0.804)26.604--5 years58.586.40.805 (0.740--0.871)27.105--6 years82.078.60.874 (0.820--0.928)27.606--7 years83.279.90.895 (0.856--0.934)28.307--8 years79.680.30.885 (0.848--0.922)28.658--9 years88.178.00.907 (0.872--0.942)30.909--10 years71.488.10.881 (0.772--0.991)Female 24.95Female 3--4 years63.678.60.741 (0.662--0.820)25.154--5 years81.474.40.823 (0.764--0.883)26.155--6 years75.081.00.839 (0.772--0.906)26.456--7 years94.773.80.921 (0.884--0.958)27.107--8 years88.676.30.897 (0.862--0.933)27.808--9 years93.679.00.924 (0.898--0.950)29.659--10 years1.0095.00.984 (0.955--1.000)Pillai et al. \[[@CR27]\]Prospective observational cross-sectionalIndiaWomen with PCOS1210/12112--41MetSMetS by IDF33.35Female60.370.70.7 (0.604--0.794)MetS by ATP III33.87Female73690.722 (0.631--0.816)Yan et al. \[[@CR9]\]Cross-sectionalChinaHealthy2092971/1121 \> 65MetSThe 2004 CDS criteria38 cm in men andMale80550.7635 cm in womenFemale75670.73ObesityBMI ≥ 25 kg/m^2^38 cm in men and 35 cm in womenMale8762NRFemale8074Kurtoglu et al. \[[@CR24]\]Case--controlTurkeyHealthy581259/3225--18MetSIDF criteria36 cm in boys and 35 cm in girlsMale61.985.60.766 (0.689--0.882)Female60.478.150.749 (0.683--0.808)Cizza et al. \[[@CR38]\]Cross-sectionalUSAObese12028/9218--50MetSIDF criteriaNO 38 cmFemale0.540.700.63de LucenaFerretti et al. \[[@CR20]\]Cross-sectionalBrazilHealthy1667751/91610--17Overw eightWHO criteria \> 34.25 in boys a nd  \> 31.25 ingirlsMale53.372.80.690 (0.649--0.730)Female61.283.00.775 (0.741--0.809)Obesity \> 37.95 in boys and  \> 32.65 ingirlsMale34.294.50.712 (0.654--0.770)Female63.890.90.815 (0.754--0.877)Yang et al. \[[@CR10]\]Cross-sectionalChinaType 2 diabetic patient31821294/188820--80MetSChinese Diabetes Society criteriaNC 39 cm for men and 35 cm for womenMale42.883.80.67 (0.63--0.70); p \< 0.001Female60.066.50.66 (0.63--0.70); p \< 0.001Central obesityWC ≥  85 cm for men and  ≥ 80 cm for womenNC 37 cm for men and 35 cm for womenMale65.173.60.77 (0.72--0.82); p \< 0.001Female64.075.90.75 (0.72--.078); p \< 0.001OverweightBMI  ≥ 24 kg/m^2^NC 38 cm for men and 35 cm for womenMale\
Female62.0 68.874.2 65.40.72 (0.69--0.75); p \< 0.001\
0.73 (0.70--0.75); p \< 0.001Zepeda et al. \[[@CR39]\]Cross-sectionalUSAHealthy1058561/4976--18High BPSystolic and/or diastolic BP\
 ≥ 95th percentile for age, sex and heightNC \> 90^,th^Male\
FemaleNRNR0.75 (0.70--0.81)\
0.72 (0.63--0.75)Katz et al. \[[@CR40]\]Cross-sectionalCanadaHealthy1913977/9366--17Overweight/obesityBMI \> 85th percentile CDCNC \> 50th percentile\
Boys: 25.3--35.5 cm Girls: 24.8--30.5 cmTotal0.9700.5000.884Lou et al. \[[@CR41]\]Cross-sectionalChinaHealthy28471475/13727--12Overweight/obesityBMI ≥ 85thBoys: 27.4--31.3 cm Girls: 26.3--31.4 cmMale\
Female\
Total0.8030.847NR0.846 0.8190.843 0.845Selvan et al. \[[@CR13]\]Cross-sectionalIndiaHealthy451258/19330--80MetSNCEPATP III \> 34.9 cm for men\
 \> 31.25 cm for womenMale\
Female78.6\
72.359.3\
64.40.753 (0.694--0.813)\
0.768 (0.687--0.849Type 2 DMNRMale\
FemaleNRNR0.453 (0.382--0.5324)\
0.439 (0.357--0.520)HypertensionNRMale\
FemaleNRNR0.535 (0.465--0.606)\
0.501 (0.416--0.586)High TGNRMale\
FemaleNRNR0.670 (0.600--0.739)\
0.546 (0.463--0.629)Low HDLNRMale\
FemaleNRNR0.611 (0.537--0.685)\
0.622 (0.537--0.707)Hatipoglu et al. \[[@CR25]\]Case--controlTurkeyOverweight/obese children and healthy ones as control967475/4926--18Overweight and obesityBMI ≥ 85th percentile of the BMI reference curve according to local referencesBoys: pre-pubertal 29.0 and pubertal 32.5 cm\
Girls: pre-pubertal 28.0 and pubertal 31.0 cmPrepubertal male86.36 (78.5--92.2)82.58 (75.0--88.6)0.889 (0.843--0.926)Pubertal male80.85 (71.4--88.2)76.26 (68.3--83.1)0.877 (0.828--0.916)Prepubertal female78.95 (68.1--87.5)85.15 (76.7--91.4)0.884 (0.828--0.927)Pubertal female83.33 (75.9--89.2)81.42 (75.0--86.8)0.896 (0.857--0.928)Atwa et al. \[[@CR42]\]Cross-sectionalEgyptHealthy27621327/143512--15Overweight/obesityBMI \> 85th CDCMen: 29.3--32.3 cm Women:28.6--30.8 cmMale\
Female\
Total0.927\
0.928\
0.9280.806\
0.670\
0.736NRLuo et al. \[[@CR11]\]Cross-sectionalChinaHealthy1943783/116058 ±7MetS ≥ 2 metabolic disorders\
But without abdominal obesityNC \> 38.5 cm for men\
NC \> 34.5 cm for womenMale\
Female50.53 (45.93--55.12)\
48.95 (44.37--53.54)67.74 (62.23--72.92)\
74.85 (71.43--78.07)NRAbdominal obesityVisceral fatarea of ≥ 80 cm^2^Male\
Female56.1\
58.183.5\
82.50.781\
0.777DiabetesFPG ≥ 6.10 mmol/Land (or) a 2hPG  ≥ 7.80 mmol/L/L, and (or) previously diagnosed diabetesMale\
Female46.33 (41.33--51.38)\
43.64 (39.12--48.25)59.79 (54.73--64.71)\
71.08 (67.53--74.44)NRHigh BPSBP ≥ 130 mmHg, and (or) DBP ≥ 85 mmHg, and (or) previously diagnosed hypertension serum TG \> 1.70 mmol/LMale\
Female48.88 (44.58--53.20)\
42.94 (39.17--46.78)68.98 (62.78--\
74.71)\
76.18 (72.14--79.90)NRHigh TGSerum TG ≥ 1.70 mmol/LMale\
Female52.82 (47.01--58.58)\
50.73 (45.29--56.16)62.66 (58.17--66.99)\
71.67 (68.45--74.74)NRLow HDL-CSerum HDL-C less than 1.04 mmol/LMale\
Female51.45 (44.95--57.92)\
58.56 (48.82--67.83)60.33 (56.07--64.48)\
67.59 (64.66--70.42)Khalangot et al. \[[@CR14]\]Cross-sectionalUkraineHealthy (not registered as T2D patients)19646/150 \> 44DMHbAlc ≥ 6.5%NO 36.5 cm for women and  \>  38.5 cm for menFemale72.2 (46.5--90.3)62.3 (53.4--70.7)0.690 (0.815--0.564)Male100 (54.1--100)38.5 (23.4--55.4)0.774 (0.682--0.866)Kumar et al. \[[@CR26]\]Cross-sectionalIndiaPatients who attended medicine clinic in a tertiary care KMC hospital431250/181Males  \>  35 and female s \> 40MetSATP 111Total: 36.5cms\
Female: 34\
Male: 37Total50.076.070Female8232NRMale6832NRGomez-Arbelaez et al. \[[@CR16]\]Cross-sectionalColombiaHealthy669351/3188--14MetSModified NHANES29 cm in boys and 28.5 cm in girlsMale10045.370.74 (0.68--0.78)Female87.5053.610.73 (0.68 --0.78)Insulin resistanceHOMA-IR22.630 cm in males and 29 cm in femalesMale52.5461.190.54 (0.49--0.59)Female50.0062.350.57 (0.51--0.62)*NC* neck circumference, *HOMA* homeostatic model assessment, *IR* insulin resistance, *HOMA*-*IR* Homeostasis Model Assessment-Insulin Resistance, *HDL*-*C* high density lipoprotein-cholesterol, *NCEP* National Cholesterol Education Program criteria, *cMetS* continuous metabolic syndrome, *CDS* Chinese Diabetes Society, *CDC* Centers for Disease Control and Prevention, *IDF* International Diabetes Federation, *MetS* metabolic syndrome, *BMI* body mass index ,*WHO* World Health Organization, *VFA* visceral fat area, *DM* diabetes mellitus, *FBS* fasting blood glucose, *HbAlc* hemoglobin Ale, *TG* triglycerides, *LDL* low density lipoprotein, *TC* total cholesterol, *WC* waist circumference, *BP* blood pressure, *NR* not reported

The highest SE values of NC for prediction of MetS was 100 in children and 80 in adults. The maximum SP was 89.5 in children and 91 in adults. The SE values to predict overweight/obesity ranged from 34 to 97 in children, and the SP was between 50 and 94. Only 2 studies included adults \[[@CR9], [@CR10]\] wherein SE was between 62 and 87 in men, and 68 and 80 in women. SP was between 62 and 74 in men, and between 65 and 74 in women. In 2 studies which reported SE and SP of NC in the prediction of abdominal obesity \[[@CR10], [@CR11]\], SE ranged from 56.1 to 68.8 and SP ranged from 65.4 to 83.5. In 2 studies which reported SE and SP of NC for prediction of hypertension among children and adolescents, maximum SE and SP were 85 and 71 in boys and 100 and 69 in girls \[[@CR12]\]. Only 3 studies assessed SE and SP of NC for the prediction of high TG and low HDL-C \[[@CR11]--[@CR13]\] wherein the highest values of SE and SP were 62 and 71, respectively.

Among 4 studies which assessed SE and SP of NC for prediction of type 2 diabetes \[[@CR11]--[@CR14]\], the maximum values of SE and SP was 80 and 67 in children \[[@CR12]\], and 100 and 72 in adults. In studies which assessed insulin resistance \[[@CR12], [@CR15], [@CR16]\], two studies reported a SE of 100 in boys, and 50 to 95 in girls. The SP was 42 to 74 in boys, and 36 to 84 in girls.

According to QUADAS-2 checklist, the study methods of all diagnostic accuracy studies met all QUADAS-2 items. However, three studies were classified as "unclear risk" in the domain of "patient selection" (third question of the first domain) \[[@CR11], [@CR15], [@CR16]\]. One studies were classified as "high risk" in the first question of the first domain (random sampling method) \[[@CR9]\]. Totally, 83.33% of the studies were considered as high quality (low risk of bias) and 91.66% were classified as low concern according to the QUADAS-2 checklist.

### A-2: Association between NC and cardiometabolic risk factors {#Sec9}

Articles which assessed association between NC and cardiometabolic risk factors were categorized into two sections: articles which assessed cardiometabolic risk factors as binary variables and reported odds ratio (OR) or relative risk (RR) in logistic regression analysis (Table [2](#Tab2){ref-type="table"}), or articles which assessed cardiometabolic risk factors as continuous variables and reported correlation coefficient or Beta coefficient in correlation or linear regression analysis (Table [3](#Tab3){ref-type="table"}).Table 2Characteristics of the included studies which assessed relationship between neck circumference and cardiometabolic risk factorsStudy**Coun tryType of studyPopulati onnMale/fe maleAgeyDiagnostic criteria of outcomeUnit of NCSex groupConfounderOutcomeMeasure of effectMeasure of associati onQuality score**Khalangot et al. \[[@CR14]\]UkraineCross-sectionalHealthy not registere dasT2D patients19646/150 \> 44HbAlc ≥ 6.5%Both sexesGender, BMIDM1.43 (1.05--1.96); p = 0.024Adjuste OR (95% CI)**8**Yan et al. \[[@CR9]\]ChinaCross-sectionalHealthy2092971/1121 \> 65According to the 2004 Chinese Diabetes Society (CDS) criteria \[[@CR1]\]Male\
FemaleAgeMetS11.53 (5.57--23.87) 7.69(4.91-12.04)Adjusted OR (95% CI) (Q4/Q1)**7**BMI ≥ 25 kg/m^2^Male\
FemaleObesity26.26 (11.02--62.57)\
17.16 (9.59--30.70)Fasting TG21.7 mmol/lMale\
FemaleHighTG3.06 (2.06--4.54)\
2.01 (1.59--2.56)Blood\
pressure \> 140/90 mmHg or known treatment for hypertensionMale\
FemaleHighBP2.41 (1.94--3.00)\
4.37 (2.81--6.7)FBS ≥ 6.1  mmol/l or known treatment for diabetesMale\
FemaleHigh FBS1.89 (1.53--2.34)\
1.68 (1.41--2.00)Zepeda et al. \[[@CR39]\]USACross-sectionalHealthy1058561/4976--8Systolic and/or diastolic BP ≥  95th percentile for age, sex and heightNC \> 90th percentileBoth sexesAge, gender and heightHigh BP1.59 (1.05--2.40)Adjusted OR (95% CI8de LucenaFerretti et al. \[[@CR20]\]Brazi1Cross-sectionalHealthy1667751/91610--17Overweight and obesity according to the definitions of WHO ≥ 34.25 in boys and  ≥  31.25 in girlsBoth sexesSex, age, weight, BMI, WC, pubertal stage, SBP, DBP, % body fatOverweight Obesity1.70 (0.85--3.39)AdjustedOR (95% CI7 ≥ 37.95 in boys and  ≥ 32.65 in girls3.26 (1.00--10.59)Pereira et al. \[[@CR17]\]Brazi1Cross-sectionalCollege students70262.7% were women20--24NCEP Adult Treatment Panel IIINeck circumference  ≥ 39 cm for men and  ≥  35 cm for womenBoth sexesSex, age, occupational situationMetS5.4 (1.4--22.1)Adjusted OR (95% CI**7**Zhou et al. \[[@CR18]\]ChinaCross sectionalHealthy42012508/169320--85MetS according to the IDF criteria\
Increased TG: ( ≥  1.7 mmol/L)\
Decreased HDL-C (≤ 1.29 mmol/L for women)\
High BP:(SBP \>  130 orDBP ≥ 85 mmHg)\
Increased FBS ( ≥  5.60 mmol/L)NC of  ≥ 37 cm for men and  ≥ 33 cm for womenMaleAge, BMI, WC and waist to hip ratioMetS1.29 (1.12--1.48)Adjusted OR (95% CI**8**High BP1.15 (1.01--1.32)Increased TG1.16 (1.02--1.33)Increased FBS1.26 (1.06--1.50)FemaleMetS1.44 (1.20--1.72)High BP1.22 (1.03--1.46)Increased TG1.42 (1.18--1.71)Increased FBS1.32 (1.06--1.65)Decreased HDL-C1.29 (1.10--1.51)Kuciene et al. \[[@CR22]\]LithuaniaCase--controlCase: hypertensive\
Control: healthy1947962/98512--15Prehypertension: SBPorDBP ≥ 90th and  \< 95th percentile\
Hypertension: SBP or DBP  ≥ 95th percentileNC at  \> 90th percentileBoth sexesAge, sexPrehypertension2.99 (1.88--4.77)Adjusted OR (95% CI)7Hypertension4.05 (3.03--5.41)Prehyper tension/hypertension3.75 (2.86--4.91)Choet al. \[[@CR19]\]South KoreaCohortHealthy35211784/173742--71DM was defined based on the WHO criteria--1st quartile: men: 35.1 cm Women: 30.7 cm\
--4th quartile: Men: 40.3 cm\
Women: 35.2 cmMale\
FemaleAge, BMI orWC, family history of DM, antihypertensive medication, TG, alanine aminotransferase, hsCRP, PRA, HbAlc, HOMA-IRandlGI, daytime sleepinessIncidence of diabetes mellitus1.746 (1.037--2.942)\
2.077 (1.068--4.038)Adjusted\
RR (95% CI**)**8Guo et al. \[[@CR43]\]ChinaCross-sectionalNormal68023631/31715--18According to The Fourth Report on the Diagnosis, Evaluation, and treatment of High Blood Pressure in Children and AdolescentsNC  ≥  90th percentileNormal weight subjectsAge, gender BMI, WCPrehyper tension1.439 (1.118--1.853)Adjusted OR (95% CI)8Overweight subjects1.161 (0.738--1.826)Obese subjects0.892 (0.429--1.854)Vallianou et al. \[[@CR44]\]GreeceCross-sectionalconsecutive adults who had visited the 'Polykliniki' General Hospital for a health check-up490194/29618--89CRP \> 0.1 mg/dLTotalAge and gender years of school, smoking, physical activity status, Diet and alcohol intakeHigh-SE C-reactive protein1.14 (1.05--1.23)Adjusted OR (95% CI)7Kelishadi et al. \[[@CR21]\]IranCross-sectionalSchool students2304311708/113356--18Overweight was considered as BMI between the 85th and 94th centiles for age and sex, obesity as BMI  ≥  95th centile; and abdominal obesity as WHtR \> 0.5.TotalAdjusted for age, sex and living areaOver weight\
General obesity\
Abdominal obesity1.07 (1.06--1.08)\
1.10 (1.08--1.11)\
1.20 (1.18--1.21)Adjusted OR (95% CI)7Zen et al. \[[@CR45]\]Brazi1Case--controlCHD patients376242/13440 years or overSignificant coronary artery disease defined by the presence of stenosis  ≥ 50% in a major epicardial coronary artery-left anterior descendent, circumflex or right coronary artery or their branches with or at least 2.5 mm of diameter41.6 cm in men and 37.0 cm in womenTotalAge, sex, years at school, smoking, hypertension, HDL-C and diabetes mellitusSignificant coronary stenosis2.4 (1.1--5.3)Adjusted OR (95% CI)7 Table 3Characteristics of the included studies on correlation between neck circumference and cardiometabolic risk factorsStudyCountryType of studyPopulationnMale/femal eAgeyAge groupConfounde rOutcomeMeasure of effectMeasure of associati onQuality scoreKurtoglu et al. \[[@CR24]\]TurkeyCase--contr olHealthy581259/3225--18Prepubertal boysBMIr = 0.759; P \<  0.001Pearson correlatio n; P-value7SBPr =  0.502; P \<  0.001DBPr =  0.335; P \<  0.001WCr = 0.820; P \<  0.001FBSr = 0.172; P = 0.046Insulinr = 0.609; P \<  0.001TCr = 0.302; P \<  0.001TGr = 0.409; P \<  0.001HDL-Cr =− 0.166; P = 0.056HOMA-IRr = 0.619; P \<  0.001Pubertal boysBMIr = 0.774; P \<  0.001SBPr = 0.452; P \<  0.001DBPr = 0.472; P \<  0.001WCr = 0.833; P \<  0.001FBSr = 0.047; P = 0.650Insulinr = 0.325; P \<  0.001TCr = 0.467; P \<  0.001TGr = 0.380; P \<  0.001HDL-Cr = − 0.304; P \<  0.001HOMA-IRr = 0.336; P = 0.001Prepubertal girlsBMIr = 0.783; P \<  0.001SBPr = 0.396; P \<  0.001DBPr = 0.317; P \<  0.001WCr = 0.853; P \<  0.001FBSr = 0.210; P = 0.031Insulinr = 0.416; P \<  0.001TCr = 0.272; P = 0.005TGr = 0.208; P = 0.032HDL-Cr = − 0.349; P \<  0.001HOMA-IRr = 0.409; P \<  0.001Pubertal GirlsBMIr = 0.778; P \<  0.001SBPr = 0.268; P \<  0.001DBPr = 0.193; P = 0.008WCr = 0.781; P \<  0.001FBSr = 0.131; P = 0.074Insulinr = 0.455; P \<  0.001TCr = 0.101; P = 0.170TGr = 0.201; P = 0.006HDL-Cr =− 0.189; P = 0.010HOMA-IRr = 0.449; P \<  0.001Silva et al. \[[@CR15]\]BrazilCross-sectio nalHealthy388169/21910--19MaleBody fat percentage and pubertyBMI Z score0.58; P \<  0.001Adjusted Pearson correlatio n; P-value6WC0.79; P \<  0.001SBP0.47; P \<  0.001DBP0.37; P \<  0.001FemalestageFBS− 0.08; P \<  0.001Fasting insulin0.29; P \<  0.001HOMA1-IR0.29; P \<  0.001TC0.08LDL-C0.14HDL-C− 0.34; P \<  0.001TG0.23; P \<  0.01BMI Z score0.48; P \<  0.001WC0.64; P \<  0.001SBP0.28; P \<  0.001DBP0.18; P \<  0.01FBS0.08;Fasting insulin0.43; P \<  0.001HOMA1-IR0.41; P \<  0.001TC0.04;LDL-C0.09;HDL-C− 0.24; P \<  0.001TG0.25; P \<  0.001Goncalves et al. \[[@CR12]\]BrazilCross sectio nalHealthy260129/13110--14TotalBody fat0.51; P \<  0.001Pearson correlatio n; P-value6WC0.74; P \<  0.001Weight0.75; P \<  0.001BMI0.88; P \<  0.001Waist to height ratio0.41; P \<  0.001WHR0.14; P \<  0.05HOMA-IR0.35; P \<  0.001Fasting insulin0.36; P \<  0.001SBP0.62; P \<  0.001DBP0.29; P \<  0.001TC− 0.27; P \<  0.001LDL-C− 0.18; P \<  0.05HDL-C− 0.27; P \<  0.001TG0.06; P \<  0.001Gomez-Arbelaez et al. \[[@CR16]\]ColombiaCross-sectio nalHealthy669351/3188--14TotalAge, gender and Tanner stageFBS0.815 ±0.244; P = 0.001Adjusted Beta ± SE7HDL-C− 1.333 ± 0.384; P = 0.001TG3.887 ± 1.014; P \<  0.001SBP1.719 ±0.205; P \<  0.001DBP1.305 ±0.173;P \<  0.001Insulin0.362 ±0.051; P \<  0.001HOMA-IR0.085 ±0.011; P \<  0.001Atwa et al. \[[@CR42]\]EgyptCross-sectio nalHealthy27621327/143512--15MaleWeightr = 0.68; P \<  0.001Pearson correlation coefficient; p-value8BMIr = 0.67; P \<  0.001WCr=0.72; P \<  0.001FemaleWeightr =  0.68; P \<  0.001BMIr = 0.65; P \<  0.001WCr = 0.63; P \<  0.001Pillai et al. \[[@CR27]\]IndiaProspective observational cross-sectionalWomen with PCOS1210/12112--41FemaleWCr = 0.758; p \< 0.001Pearson correlation coefficients6Vallianou et al. \[[@CR44]\]GreeceCross-sectio nalConsecutive adults who had visited the 'Polykliniki' GeneralHos pital for a health check-up490194/29618--89Age, gender, years of school, smoking, physical activity, diet, alcohol intakeSBP0.97 (0.41--1.54); p =  0.001Adjusted Beta (95% CI)7DBP0.66 (0.31--1.01); P \<  0.0001FBS0.003 (0.001--0.005); p =  0.003HDL-C_1.37 (\_1.77--0.97); p \<  0.0001LDL-C1.15 (\_0.05--2.34); p = 0.06TC1.01 (\_0.33--2.35); p = 0.14TG0.02 (0.01--0.03); p \<  0.0001Zepeda et al. \[[@CR39]\]USACross-sectionalHealthy1058561/4976--18MaleWCr =  0.78; P \<  0.001Pearson correlation coefficients; p-value8BMIr = 0.72; P \<  0.001SBPr =  0.44; P \<  0.001DBPr = 0.23; P \<  0.001WHtRr = 0.25; P \<  0.001FemaleWCr = 0.83; P \<  0.001BMIr = 0.71; P \<  0.001SBPr = 0.41; P \<  0.001DBPr = 0.28; P \<  0.001WHtRr =  0.49; P \<  0.001Luo et al. \[[@CR11]\]ChinaCross-Healthy1943783/116058 ±7MaleSeveralTrunk FM0.444; P \<  0.001Adjusted8sectionalmetabolic and body fat parameter svisceral fat area0.138; P \<  0.001Beta; p-valueSubcutaneous fat area0.208; P \<  0.001SBP0.052; P =  0.039FemaleTrunk FM0.519; P \<  0.001visceral fat area0.144; P \<  0.001Subcutaneous fat area0.053; P =  0.032SBP0.098; P \<  0.001Lou et al. \[[@CR41]\]ChinaCross-sectionalHealthy28471475/13727--12MaleWeightr =  0.841; P \<  0.001Pearson correlation coefficient; p-value8BMIr =  0.800; P \<  0.001WCr =  0.809; P \<  0.001FemaleWeightr =  0.785; P \<  0.001BMIr =  0.736; P \<  0.001WCr =  0.739; P \<  0.001Selvan et al. \[[@CR13]\]IndiaCross-sectio nalHealthy451258/19330--80MaleAgeWCr =  0.742; P \<  0.001Adjusted Pearson correlation coefficient; p-valueBMIr =  0.744; P \<  0.001SBPr =  0.106DBPr =  0.113FBSr =  0.025TCr =  0211; P \<  0.05TGr =  0.365; P \<  0.001LDL-Cr =  0.185HDL-Cr =  = − 0.319; P \<  0.01FemaleWCr =  0.713; P \<  0.001BMIr =  0.682; P \<  0.01SBPr =  0.172DBPr =  0.028FBSr =  0.221TCr= 0.003TGr =  0.112LDL-Cr =  =  0.092HDL-Cr = -0.327; P \<  0.01Katz et al. \[[@CR40]\]CanadaCross-sectionalHealthy1913977/9366--17Healthy-weight maleAgeBMI0.75 (0.62--0.88)Adjusted Beta (95% CI)8Overweight/ob ese maleBMI0.46 (0.38--0.54)Healthy-weight maleWC0.24 (0.18--0.3)Overweight/ob ese maleWC0.16 (0.13--0.18)Healthy-weightBMI0.42 (0.37--0.47)femaleOverweight/ob ese femaleBMI0.37 (0.26--0.48)Healthy-weight femaleWC0.15 (0.12--0.17)Overweight/ob ese femaleWC0.15 (0.13--0.17)Formisano et al. \[[@CR23]\]Italy, Belgium, Cyprus, Estonia, Germany, Hungary, Spain and SwedenCross-sectionalHealthy156737962/77113--10BoysBMI z-score and country of originWC z-score0.318; P \<  0.001Adjusted Pearson correlation coefficient; p-value8SBPz-score0.030DBP z-score− 0.017HDL-C z-score− 0.060; P \<  0.001TG z-score0.056; P \<  0.001HOMA index z-score0.068; P \<  0.001GirlsWC z-score0.357; P \<  0.001SBPz-score0.050; P \<  0.005DBP z-score− 0.011HDL-C z-score− 0.056; P \<  0.005TG z-score0.063; P \<  0.001HOMA index z-score0.111; P \<  0.001Cizza et al. \[[@CR38]\]USACross-sectionalObese12028/9218--50TotalMetS scorer =  0.458; p \<  0.001Pearson correlation coefficient; p-value6Fasting insulinr =  0.476; P  \<  0.001HOMA indexr =  0.461; P \<  0.001Visceral fatr =  0.674, P \<  0.001Subcutaneous fatr =  0.125, P  =  0.20Total\
abdominal\
fat%r =  0.482, P \<  0.001Yang et al. \[[@CR10]\]ChinaCross-sectionalType 2 diabetic patients31821294/188820--80Male FemaleBMIr =  0.41; P \< 0.0001 r = 0.84; P \< 0.0001Pearson correlation coefficient; p-value8Male FemaleWC*r* =  0.47; *P* \<  0.0001 r = 0.47; P \<  0.0001Kumar et al. \[[@CR26]\]IndiaCross-sectionalPatients who attended medicine431250/181Males  \>  35 and females  \> 40TotalBMI0.492; P  \< 0.001Pearson correlation coefficient;7WC0.453; P \< 0.001Hip0.458; P \< 0.001W/H RATIO− 0.005; P  =  0.912Clinic in a tertiary care KMC hospitalSBP0.243; P  \< 0.001p-valueDBP0.107; P=0.027FBS0.166; P \< 0.001TC0.266; P \< 0.001LDL0.344; P \< 0.001HDL− 0.173; P \< 0.001TG0.280; P  \< 0.001Rao et al. \[[@CR46]\]IndiaCross-sectionalPatients who visited medicine OPD of a tertiary care teaching hospital250180/7040--100TotalSBP0.194056; P  =  0.002Pearson correlation coefficient; p-value6DBP0.176716; P =  0.005Li et al. \[[@CR47]\]ChinaCross sectionalPatients who took lower abdomen and neck CT examination s17787/9035--75Men\
WomenAgeVisceral adipose tissue (VAT)r  =  0.49, p \< 0.00 r  =  0.25, p  =  0.012Adjusted Pearson correlation coefficient; p-value6Men\
WomenSubcutaneous adipose tissue (SAT)r  =  0.59, p \<  0.001\
r  =  0.41, p \<  0.001Zhou et al. \[[@CR18]\]ChinaCross sectionalfrom the Examination Centre42012508/169320--85MaleAgeSBPr =  0.250; p \<  0.01Adjusted Pearson correlation coefficient; p-value8DBPr =  0.261; p \<  0.01FBGr =  0.177; p \<  0.01TGr =  0.240; p \<  0.01HDL-Cr =  − 0.202; p\<0.01TCr = 0.143; p \<  0.01LDL-Cr =  0.088; p \<  0.01FemaleSBPr =  0.255; p \<  0.01DBPr =  0.189; p \<  0.01FBGr= 0.180; p \<  0.01TGr =  0.199; p \<  0.01HDL-Cr =  − 0.234; p\<0.01TCr =  0.039LDL-Cr =  0.075; p \<  0.01Saka et al. \[[@CR48]\]TurkeyCross-sectionalHealthy411174/23720--60Men\
WomenBody weightr = 0.576; p=0.000Pearson correlation coefficient7r = 0.702; p = 0.000Men\
WomenWCr = 0.593; p = 0.000r = 0.667; p = 0.000\*Men\
WomenHip circumferencesr = 0.568; p=0.000 r = 0.617; p = 0.000Men WomenBMIr=0.58; p = 0.000 r = 0.688; p = 0.000Androutsos et al. \[[@CR28]\]Greece.Cross-sectionalHealthy324167/1579--13TotalAge, gender, Tanner stage, physical activity, and protein-, carbohydrate- and fat-dietary intakeTC− 0.200 ± 0.777Adjusted (β ± SE)7HDL− 1.713 ± 0.376LDL1.016 ±0.669Fasting glucose0.285 ±0.217SBP2.082 ±0.273DBP0.465 ±0.234TG0.037 ±0.009Insulin0.064 ±0.014HOMA-IR0.067 ±0.014MaleTCr = − 0.11Pearson's correlation coefficientHDLr = − 0.32, p\<0.001LDLr = 0.04FBSr=0.10SBPr = 0.43, p \< 0.001DBPr = 0.02TGr = 0.12Insulinr=0.23, p \< 0.001HOMA-IRr = 0.23, p \< 0.001FemaleTCr = − 0.11HDLr = − 0.23, p\<0.001LDLr = 0.05FBSr = 0.11SBPr=0.43, p \< 0.001DBPr = 0.20,p \< 0.05TGr=0.22, p \< 0.05Insulinr = 0.35, p \< 0.001HOMA-IRr = 0.36, p \< 0.001TotalTCr =  = − 0.10HDLr = − 0.27, p\<0.001LDLr =  = 0.01FBSr = 0.11SBPr = 0.43, p \< 0.001DBPr = 0.09TGr = 0.15, p \< 0.001Insulinr = 0.26, p \< 0.001HOMA-IRr = 0.26, p \< 0.001Joshipura et al. \[[@CR49]\]San Juan, USACross-sectionalOverweight/ obese, nondiabetic Hispanics120654.6% male40--65TotalAge, gender, smoking status, physical activityBMIR = 0.66; p \< 0.001Adjusted Pearson correlation coefficient; p-value8WCR = 0.64; p \< 0.001% body fatR = 0.45; p \< 0.001HOMA-IRR = 0.45; p \< 0.05FBSR = 0.10; p \< 0.001HbAlcR = 0.28; p \< 0.001SBPR = 0.18; p \< 0.001HDL-CR = − 0.23; p\<0.001DBPR = 0.23;p \< 0.001TGR = 0.12; p \< 0.05Hs-CRPR = 0.30; p \<0.001Hassan et al. \[[@CR29]\]EgyptCross-sectional case control50 healthy, 50 obese children10052/487--12Metabolic subjectsWeight0.631;P = 0.001Pearson correlation coefficient; p-value6BMI0.239; P = 0.240WC0.465; P = 0.017Waist/Hip− 0.113; P = 0.582SBP0.289; P = 0.152DBP0.445; P = 0.023LDL0.122; P = 0.551HDL− 0.120; P = 0.559TC0.056;P =  0.787TG− 0.253; P = 0.212FBS− 0.377; P = 0.058Fasting Insulin0.219; P = 0.283HOMA-IR0.113;P =  0.583Non metabolic subjectsWeight0.619; P =  0.001BMI0.535;P =  0.007WC0.605; P =  0.002Waist/Hip− 0.203; P =  0.340SBP0.048; P =  0.823DBP0.186; P =  0.384LDL− 0.444; P =  0.030HDL− 0.139; P =  0.516TC− 0.221; P =  0.299TG0.314; P =  0.135FBS− 0.137; P =  0.524Fasting Insulin0.119; P =  0.580HOMA-IR0.116; P =  0.591Cho et al.\[[@CR19]\]SouthConorHealthy35211784/173742--71MaleSBP0.170; P \< 0.001Pearson8KoreatDBP0.200; P \< 0.001Correlation coefficient; p-valueBMI0.801; P \< 0.001WC0.740; P \< 0.001Body fat (%)0.547; P \< 0.001FPG0.159; P \<  0.001HOMA-IR0.317; P \<  0.001TG0.240; P \<  0.001HDL-C− 0.246; P \<  0.001FemaleSBP0.203; P \<  0.001DBP0.199; P \<  0.001BMI0.744; P \<  0.001WC0.706; P \<  0.001Body fat (%)0.510; P \<  0.001FPG0.122; P \<  0.001HOMA-IR0.234; P \<  0.001TG0.256; P \<  0.001HDL-C− 0.223; P \<  0.001Guo et al. \[[@CR43]\]ChinaCross-sectio nalNormal68023631/31715--18Normal weightAge, gender, BMI, WCBMIr = 0.226; P \<  0.001Adjusted Pearson correlation coefficient; p-value8WCr = 0.339; P \<  0.001SBPr = 0.449; P \<  0.001DBPr = 0.328; P \<  0.001OverweightBMIr = 0.137; P \<  0.001WCr = 0.348; P \<  0.001SBPr = 0.459; P \<  0.001DBPr = 0.344; P \<  0.001ObeseBMIr = − 0.004;P =  0.932WCr = 0.635; P \<  0.001SBPr = 0.477; P \<  0.001DBPr = 0.325; P \<  0.001Hatipoglu et al. \[[@CR25]\]TurkeyCase--controlOverweight/ obese children and healthy ones as control967475/4926--18Boys prepubertal pubertal\
Girls prepubertal pubertalBMIr =  0.700; P \< 0.001 r =  0.821; P \< 0.001\
r =  0.727; P \< 0.001 r =  0.848; P\<0.001Pearson correlation coefficient; p-value8Boys\
Prepubertal\
Pubertal\
Girls\
Prepubertal\
PubertalWCr =  0.733; P \< 0.001 r =  0.839; P \< 0.001\
r =  0.776; P \< 0.001 r =  0.854; P\<0.001Kelishadi et al. \[[@CR21]\]IranCross-School2304311708/1136--18MaleAge, sexWeightr =  0.546; p \<  0.001Adjusted7sectionalstudents35and living areaBMIr =  0.389; p \< 0.001Pearson correlation coefficient; p-valueWCr =  0.491; p \<  0.001Waist/Hipr =  0.035; p \<  0.001Waist/Heightr =  0.156; p \<  0.001Hipr =  0.505; p \<  0.001FemaleWeightr =  0.481; p \<  0.001BMIr =  0.387; p \<  0.001WCr =  0.456; p \<  0.001Waist/Hipr = − 0.020; p \<  0.001Waist/Heightr =  0.222; p \<  0.001Hipr =  0.464; p \<  0.001TotalWeightr =  0.519; p \<  0.001BMIr =  0.384; p \<  0.001WCr =  0.479; p \<  0.001Waist/Hipr =  0.023; p \<  0.001Waist/Heightr =  0.188; p \<  0.001Hipr =  0.478; p \<  0.001

Table [2](#Tab2){ref-type="table"} lists characteristics of studies reporting OR/RR of high NC and the risk of cardiometabolic risk factors (n = 13). Most of them were designed as cross-sectional (n = 10) and the rest as case--control (n = 2) or cohort (n = 1). The studies were carried out in different countries including China (n = 3), Brazil (n = 3), Greece (n = 2), and one study in Ukraine, USA, Iran, Lithuania, and South Korea. In 6 studies, children and adolescents were included, and 7 reports were on adult populations. The articles have been published between 2012 and 2017.

Three studies in adults assessed the OR of high NC in prediction of MetS presence \[[@CR9], [@CR17], [@CR18]\]. Among them, Yan et al. found the strongest association between high NC and MetS in both elderly men and women, with ORs of 11.53 and 7.69, respectively \[[@CR9]\]. The association between high NC and DM was reported in few studies \[[@CR9], [@CR14], [@CR18], [@CR19]\] where in ORs or RRs varied between 1.26 (1.06--1.50) and 2.07 (1.06--4.03).

Three studied reported the association between high NC and obesity. Among children and adolescents, ORs was between 1.07 and 1.70 for the prediction of overweight, and 1.10 to 3.25 for prediction of obesity \[[@CR20], [@CR21]\].Yan et al. found again a strong association between high NC and obesity among elderly men and women, with ORs of 26.26 and 17.16, respectively \[[@CR9]\].

In two studies which assessed the association between high NC and high TG \[[@CR9], [@CR18]\], the ORs were between 1.16 and 3.06. In regard to high BP, Kuciene et al. \[[@CR22]\] found that greater NC was associated with 4 times risk for hypertension. Among adults, Yan et al. \[[@CR9]\] found OR of 2.41 and 4.37 in elderly men and women, respectively.

Table [3](#Tab3){ref-type="table"} shows association studies where both NC and cardiometabolic risk factors were reported continuous variables. A total of 27 studies were found (14 publications included children and adolescents, and 13 studies in adults). Most of them used correlation coefficients, and few ones used beta regression coefficients for statistical analyses. The articles were published between 2010 and 2017. The studies were carried out in different countries including China (n = 6), India (n = 4), USA (n = 3), Turkey (n = 3), Brazil (n = 2), Egypt (n = 2), Greece (n = 2), and one study in Iran, Canada, Europe, Colombia, and South Korea.

Out of 18 studies which assessed the correlation between NC and BMI, 11 articles included children and adolescents. Significant correlations were found between NC and BMI. The *r* ranged from 0.38 \[[@CR21]\] to 0.88 \[[@CR12]\] in adolescents. In adults, *r* ranged from 0.41 to 0.84 in men and women together.

There was a significant association between WC and NC in all 20 studies (13 reports in children and adolescents, and 8 studies in adults). The *r* ranged from 0.318 \[[@CR23]\] to 0.85 \[[@CR24], [@CR25]\] among children and adolescents. In adults, *r*-values was between 0.45 \[[@CR26]\] and 0.75 \[[@CR27]\].

Out of 18 studies which reported the correlation between NC and blood pressure, 9 publications were on children and adolescents. A wide range of *r* was found; from 0.02 \[[@CR28]\] to 0.62 \[[@CR12]\]. In some studies, the correlation was not significant \[[@CR13], [@CR28], [@CR29]\].

Weak correlations was observed between NC and FBS in 12 relevant studies, (*r* ranged from − 0.377 to 0.27 \[[@CR29], [@CR30]\]). Eleven studies also reported correlation between fasting insulin, HOMA-IR or both with NC. The *r*-values for these two variables were very close, ranging from 0.21 to 0.61 \[[@CR24], [@CR30]\].

Fourteen studies reported correlation coefficients of blood TC, TG, HDL-C, or LDL-C with NC. Findings of correlation between TC and NC was not conclusive; *r*-values ranged from − 0.27 \[[@CR12]\] to 0.302 \[[@CR24]\]. Blood TG was positively correlated with NC in all reports \[*r* ranged from 0.06 \[[@CR12]\] to 0.409 \[[@CR24]\]. There was negative correlation between HDL-C and NC in all relevant publications, with *r* ranging from − 0.120 \[[@CR29]\] to − 0.35 \[[@CR30]\]. Weak and mostly not significant correlations between LDL-C and NC were observed.

According to the Newcastle--Ottawa checklist, all selected studies were categorized as high quality study and attained score ≥ 6 according to this scale. Overall, 20% of studies attained 6 scores, 38% of studies attained 7 scores and the rest got the score of 8 (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}).

Results of quantitative synthesis {#Sec10}
---------------------------------

### B-1: The diagnostic accuracy of high NC to predict MetS {#Sec11}

The results of heterogeneity statistics about the SE of high NC to predict MetS according to sex and age groups showed sever heterogeneity in SE existed between studies in male (I^2^: 97.9%; Q test: 335.85, p \< 0.001), female (I^2^: 91.1%; Q test: 112.26, p \< 0.001), pediatric (I^2^: 91.1%; Q test: 33.75, p \< 0.001), adult (I^2^: 96.2%; Q test: 391.78, p \< 0.001), and overall population (I^2^: 96%; Q test: 479.02, p \< 0.001). Due to sever heterogeneity between studies, the random effect meta-analysis was used and the pooled SE in male, female, pediatric, adult and overall population was estimated 69% (95% CI 56--83), 67% (95% CI 60--74), 77% (95% CI 55--99), 65% (95% CI 58--72) and 67% (95% CI 61--74), respectively (Additional file [1](#MOESM1){ref-type="media"}: Figure S1:A--D). The results of heterogeneity statistics for SP of high NC to predict MetS indicated sever heterogeneity among studies in both sexes and age groups. The random effect meta-analysis showed that the pooled SP in male, female, adult, pediatric and overall population was 64% (95% CI 52, 75), 67% (95% CI 60, 74),66% (95% CI 60, 72), 66% (95% CI 48, 84) and 66% (95% CI 60, 73), respectively (Additional file [2](#MOESM2){ref-type="media"}: Figure S2: E--H).

Publication bias: Begg᾽s test confirmed no publication bias for sensitivity (p = 0.32) and specificity (p = 0.92) of high NC for predicting MetS.

### B-2: The association of NC with glycemic indices in adult populations {#Sec12}

FBS: The pooled estimates of 4 studies (seven effect sizes) indicated that there was a significant positive correlation between NC and serum levels of FBS (CC: 0.16, 95% CI 0.13, 0.20). However, the heterogeneity was high (I^2^: 56.0%, p = 0.03) (Additional file [3](#MOESM3){ref-type="media"}: Figure S3:1). Subgroup analysis based on age, sex and continent are presented in Additional file [4](#MOESM4){ref-type="media"}: Table S1. After stratification by continent (Asian, Non-Asian), we found that the association between NC and FBS concentrations in Asian population (CC: 0.19, 95% CI 0.16, 0.22; I^2^:0, p = 0.61) was stronger than Non-Asian (CC: 0.13, 95% CI 0.10, 0.16; I^2^: 28.3%, p = 0.24). This parameter attenuated the heterogeneity greater than gender subgroups.

HOMA-IR: The association between NC and HOMA-IR was reported in three studies containing four effect sizes. The overall effect size showed a significant link between NC and HOMA-IR (CC: 0.38, 95% CI 0.25, 0.50) in adult population, while the heterogeneity was high (I^2^: 93.5%, p = 0.0001) (Additional file [3](#MOESM3){ref-type="media"}: Figure S3:2). Due to limited studies, it was not possible to perform subgroup analysis to find the reason of the heterogeneity.

### B-3: The association of NC with lipid profile in adult populations {#Sec13}

Based on the overall effect size, in subjects who had higher NC, serum levels of TC was higher than those with smaller one (CC: 0.12, 95% CI 0.05, 0.19; I^2^: 79.2, p = 0.001) (Additional file [3](#MOESM3){ref-type="media"}: Figure S3:3). After stratification by age, a notable reduction was observed in the heterogeneity (Additional file [4](#MOESM4){ref-type="media"}: Table S1). Besides, pooling 8 effect sizes revealed that there was a significant correlation between NC and TG concentrations (CC: 0.23, 95% CI 0.19, 0.28; I^2^: 76.2%, p = 0.001) (Additional file [3](#MOESM3){ref-type="media"}: Figure S3:4). However, after subgroup analysis the heterogeneity did not attenuate considerably (Additional file [4](#MOESM4){ref-type="media"}: Table S1). Meta-analysis on LDL-C concentrations also showed a positive association with NC (CC: 0.14, 95% CI 0.07, 0.22); however, the heterogeneity was high (I^2^: 79.2%, p = 0.001) (Additional file [3](#MOESM3){ref-type="media"}: Figure S3:5). Subgroup analysis showed that this association in men (CC: 0.13, 95% CI 0.03, 0.22; I^2^: 59.1%, p = 0.11) was stronger than women (CC: 0.08, 95% CI 0.03, 0.13; I^2^: 0%, p = 0.81).

Publication bias: Egger᾽s test showed no publication bias for FBS (p = 0.49), HOMA-IR (p = 0.57), TC (p = 0.92), TG (p = 0.93) and LDL-C (p = 0.25).

### B-4: The association of NC with glycemic indices in child populations {#Sec14}

FBS: From five studies in which the association between NC and FBS concentrations was reported, 12 effect sizes were extracted. The pooled estimates showed that children with greater NC had higher levels of FBS compared to those with smaller one (CC: 0.12, 95% CI 0.07, 0.16; I^2^:48.4%, p = 0.03) (Additional file [5](#MOESM5){ref-type="media"}: Figure S4:1). No severe heterogeneity was found for this association.

HOMA-IR: The correlation between NC and HOMA-IR was reported in 6 studies including 11 effect sizes. Based on findings, greater NC was correlated with higher HOMA-IR (CC: 0.27, 95% CI 0.23, 0.31). However, the heterogeneity was considerably high (I^2^: 93.2%, p = 0.0001) (Additional file [5](#MOESM5){ref-type="media"}: Figure S4:2).

### B-5: The association of NC with lipid profile in child populations {#Sec15}

The pooled estimates (n = 12) of five studies showed a significant positive link between NC and TC concentrations (CC: 0.07 95% CI 0.02, 0.12; I^2^:87.8%, p = 0.001), although it was a weak correlation (Additional file [5](#MOESM5){ref-type="media"}: Figure S4:3). Findings of six studies also revealed a significant link between NC and TG levels (CC: 0.21, 95% CI 0.17, 0.25; I^2^:61.2%, p = 0.001) (Additional file [5](#MOESM5){ref-type="media"}: Figure S4:4). However, no correlation was obtained between NC and LDL-C (CC: 0.01, 95% CI − 0.06, 0.07; I^2^:65.9%, p = 0.005) (Additional file [5](#MOESM5){ref-type="media"}: Figure S4:5). Due to limited studies on children, subgroup analyses were not possible.

Publication bias: Begg᾽s test confirmed no publication bias for FBS (p = 0.19), HOMA-IR (p = 0.38), TC (p = 0.37), TG (p = 0.58) and LDL-C (p = 0.06).

Discussion {#Sec16}
==========

The current systematic review and meta-analysis revealed a positive association of NC, glycemic status and lipid profile in adult and child populations. However, no correlation was observed between NC and LDL-C concentrations in children. In general, due to high heterogeneity the findings should be declared with caution. Moreover, the association between NC and other cardio-metabolic risk factors were significant in most studies. However, because of limited studies drawing a certain decision needs further studies. Although the SE and the SP of NC to predict MetS were greater than about 65% in both child and adult populations, the between-study heterogeneity was considerably high.

To the best of our knowledge, the present study is the first study that examined the association of NC and cardio-metabolic risk factors in all age ranges and determined the SE and the SP of NC to predict MetS. In the present study, subgroup analysis revealed that the link between serum levels of FBS and NC in Asian was stronger than other adult populations. Findings on children populations also showed that the link between NC and FBS was significant only in Asian populations. Additionally, in Asian children the link between insulin resistance and NC was stronger than non-Asians.

These findings showed that race can play a main role in this correlation. Besides, the correlation between NC and LDL-C levels in men was stronger than the correlation in adult women. Therefore, gender can be another factor that affects the association. Energy intake, physical activity level, and menopause status are possible factors that can affect the link. In the present study, some included studies did not control such factors and it is likely to cause bias in the findings.

Another factor in the association between NC and cardio-metabolic risk factors is likely to be study design. In the present systematic review, design in most studies was cross-section. The weakness of this kind of study is inability to clarify a cause and effect relationship. Prospective cohort studies can shed light on the type of the association.

Although prior studies introduced WC as a good predictor for cardio-metabolic risks \[[@CR31], [@CR32]\], it has some limitations. For instance, several sites including midway between rib cage and iliac crest, the lower border of rib cage, and iliac crest umbilicus are used for measuring WC. This resulted in different values for WC. Moreover, time of measurement, the state of expiration and fullness affect the measure \[[@CR29], [@CR33]\]. However, NC measurement is easy and accessible. Besides, a unit site for measurement was reported among the studies. NC is measured above the cricoid cartilage and perpendicular to the long axis of the neck \[[@CR34], [@CR35]\]. Due to no variation in the measurement of NC, multiple measurements are not needed to be sure about its accuracy.

Compare to BMI, NC has some strength points. NC is measured faster and does not need special tools \[[@CR9]\]. Therefore, particularly for epidemiological assessment it seems to be a good predictor. However, due to the high heterogeneity, more studies are needed to clarify its efficacy.

In the present study, we found that the association of NC with obesity, diabetes, hypertension, and MetS were significant in most studies. However, due to limited studies we cannot draw a fix conclusion about these issues. In addition, as there has been no meta-analysis on the SE and the SP of NC as a predictor for MetS, we could not compare our results with previous findings. Based on a systematic review by Arias et al., there was a positive association between NC and adiposity parameters indirectly measured by reference methods including dual-energy x-ray absorptiometry (DXA) and computed tomography (CT) in adult population. However, they reported no study on children in this regard \[[@CR50]\].

The mechanisms that explain the association between neck adipose tissue and cardio-metabolic risk factors are not precisely identified. It is likely that high plasma free fatty acids (FFAs) provide a ground for developing metabolic disorders \[[@CR36]\]. Increasing in the levels of FFAs can result in oxidative stress and vascular injury \[[@CR15], [@CR36]\]. The main releasing rate of systemic FFA is dedicated to upper body subcutaneous fat \[[@CR5], [@CR36]\]. Accordingly, NC can be a suitable predictor for CVD risk factors.

The present study has two main limitations: \[[@CR1]\] due to cross-sectional design in the most included studies a cause and effect relationship was not clarified. \[[@CR2]\] Heterogeneity mostly remained high even after stratification by possible confounders. The main strength of the present systematic review was to determine the SE and SP of NC in adult and child populations.

Conclusion {#Sec17}
==========

Although the SE and the SP of NC to predict MetS were acceptable in both child and adult population, the between-study heterogeneity was considerably high. There is a positive association between NC and glycemic indices, and lipid profile in adult and pre-pubertal populations. However, no correlation was observed between NC and LDL-C concentrations in children. Due to high heterogeneity, the findings should be declared with caution. Although the association between NC and other cardio-metabolic risk factors were significant in most studies, due to limited publications in this regard more prospective cohort studies are needed to clarify these associations.
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**Additional file 1: Figure S1.** Forest plot of high neck circumference sensitivity for predicting metabolic syndrome in A) male, B) female, C) children, D) adult population. **Additional file 2: Figure S2.** Forest plot of high neck circumference specificity for predicting metabolic syndrome in E) male, F) female, G) children, H) adult population. **Additional file 3: Figure S3.** Forest plot of the association of neck circumference and 1) FBS, 2) HOMA, 3) TC, 4) TG, 5) LDL-C in adult population. **Additional file 4: Table S1.** Subgroup analysis for the association between neck circumference and cardio-metabolicfactors in adult population. **Additional file 5: Figure S4.** Forest plot of the association of neck circumference and 1) FBS, 2) HOMA, 3) TC, 4) TG, 5) LDL-C in child population.
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